Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jarman

Showing results (151-160 of 189) with videos related to

Pageof 19
Sort By:
Journal of Medicinal Chemistry|August 16, 1996
3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancerF C Chan, G A Potter, S E Barrie, et al.
Lancet (London, England)|December 18, 1993
Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentrationS R Johnston, B P Haynes, I E Smith, et al.
Journal of Medicinal Chemistry|December 24, 1993
Synthesis and cytotoxicity of potential tumor-inhibitory analogues of trimelamol (2,4,6-tris[(hydroxymethyl)methylamino]-1,3,5-triazine) having electron-withdrawing groups in place of methylM Jarman, H M Coley, I R Judson, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1997
Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P450(17alpha) inhibitorsS E Barrie, B P Haynes, G A Potter, et al.
Biochemical Pharmacology|September 1, 1993
Identification, synthesis and properties of 5-(aziridin-1-yl)-2-nitro-4-nitrosobenzamide, a novel DNA crosslinking agent derived from CB1954R J Knox, F Friedlos, P J Biggs, et al.
Journal of Medicinal Chemistry|February 1, 1985
Analogues of aminoglutethimide: selective inhibition of aromataseA B Foster, M Jarman, C S Leung, et al.
Bulletin of Environmental Contamination and Toxicology|July 1, 1996
High levels of HCB and DDE associated with reproductive failure in prairie falcons (Falco mexicanus) from CaliforniaW M Jarman, S A Burns, C E Bacon, et al.
Carcinogenesis|April 1, 1995
The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifenM Jarman, G K Poon, M G Rowlands, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials CommitteeD M Vigushin, G K Poon, A Boddy, et al.
Nuclear Medicine and Biology|May 1, 1995
Pharmacokinetics and biodistribution of radiolabelled idoxifene: prospects for the use of PET in the evaluation of a novel antioestrogen for cancer therapyH Young, P Carnochan, M Trivedi, et al.
Pageof 19

Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
Journal of Medicinal Chemistry|August 16, 1996
3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancerF C Chan, G A Potter, S E Barrie, et al.
Lancet (London, England)|December 18, 1993
Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentrationS R Johnston, B P Haynes, I E Smith, et al.
Journal of Medicinal Chemistry|December 24, 1993
Synthesis and cytotoxicity of potential tumor-inhibitory analogues of trimelamol (2,4,6-tris[(hydroxymethyl)methylamino]-1,3,5-triazine) having electron-withdrawing groups in place of methylM Jarman, H M Coley, I R Judson, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1997
Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P450(17alpha) inhibitorsS E Barrie, B P Haynes, G A Potter, et al.
Biochemical Pharmacology|September 1, 1993
Identification, synthesis and properties of 5-(aziridin-1-yl)-2-nitro-4-nitrosobenzamide, a novel DNA crosslinking agent derived from CB1954R J Knox, F Friedlos, P J Biggs, et al.
Journal of Medicinal Chemistry|February 1, 1985
Analogues of aminoglutethimide: selective inhibition of aromataseA B Foster, M Jarman, C S Leung, et al.
Bulletin of Environmental Contamination and Toxicology|July 1, 1996
High levels of HCB and DDE associated with reproductive failure in prairie falcons (Falco mexicanus) from CaliforniaW M Jarman, S A Burns, C E Bacon, et al.
Carcinogenesis|April 1, 1995
The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifenM Jarman, G K Poon, M G Rowlands, et al.
Cancer Chemotherapy and Pharmacology|July 8, 1998
Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials CommitteeD M Vigushin, G K Poon, A Boddy, et al.
Nuclear Medicine and Biology|May 1, 1995
Pharmacokinetics and biodistribution of radiolabelled idoxifene: prospects for the use of PET in the evaluation of a novel antioestrogen for cancer therapyH Young, P Carnochan, M Trivedi, et al.
Pageof 19